Geun Dong Lee1, Do Kyun Kang2, Hyeong Ryul Kim1, Se Jin Jang3, Yong-Hee Kim1, Dong Kwan Kim1, Seung-Il Park1. 1. Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. 2. Department of Thoracic and Cardiovascular Surgery, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea. 3. Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract
BACKGROUND: The aim of the present study was to evaluate the oncologic characteristics of pulmonary mucoepidermoid carcinoma (PMEC) and the efficacy of surgical resections. MATERIALS AND METHODS: The surgery for PMEC was performed in 23 patients at Asan Medical Center from January 2000 to December 2010. They accounted for 0.8% of all surgically resected pulmonary neoplasm in the center. The medical records of these patients were reviewed retrospectively. RESULTS: This study group was composed of 13 males (56.5%) and 10 females (43.5%). Median age was 41 years (range, 10 to 75 years). Complete resection with systematic mediastinal lymph node dissection was performed in all patients. There were three postoperative complications: atelectasis in one patient and chylothorax in two patients. There was no postoperative mortality. The median follow-up duration was 68 months (range, 13 to 115 months). In one patient, recurrent disease was found 73 months after surgery. All patients were followed without mortality until the end of this study. The 5- and 8-year disease-free survival rates were 100 and 90.9%, respectively. CONCLUSION: Complete surgical resection with systematic lymph node dissection is an effective treatment for patients with PMEC and provides favorable prognosis. Georg Thieme Verlag KG Stuttgart · New York.
BACKGROUND: The aim of the present study was to evaluate the oncologic characteristics of pulmonary mucoepidermoid carcinoma (PMEC) and the efficacy of surgical resections. MATERIALS AND METHODS: The surgery for PMEC was performed in 23 patients at Asan Medical Center from January 2000 to December 2010. They accounted for 0.8% of all surgically resected pulmonary neoplasm in the center. The medical records of these patients were reviewed retrospectively. RESULTS: This study group was composed of 13 males (56.5%) and 10 females (43.5%). Median age was 41 years (range, 10 to 75 years). Complete resection with systematic mediastinal lymph node dissection was performed in all patients. There were three postoperative complications: atelectasis in one patient and chylothorax in two patients. There was no postoperative mortality. The median follow-up duration was 68 months (range, 13 to 115 months). In one patient, recurrent disease was found 73 months after surgery. All patients were followed without mortality until the end of this study. The 5- and 8-year disease-free survival rates were 100 and 90.9%, respectively. CONCLUSION: Complete surgical resection with systematic lymph node dissection is an effective treatment for patients with PMEC and provides favorable prognosis. Georg Thieme Verlag KG Stuttgart · New York.
Authors: Byungjoon Park; Hong Kwan Kim; Yong Soo Choi; Jhingook Kim; Jae Il Zo; Joon Young Choi; Young Mog Shim Journal: Korean J Radiol Date: 2015-07-01 Impact factor: 3.500
Authors: Ryan Thibodeau; Abtin Jafroodifar; Marlon Coelho; Benjamin Kaminski; Lorenzo Gitto; Daniel J Zaccarini; Ernest Scalzetti Journal: Radiol Case Rep Date: 2021-06-11
Authors: Xuanguang Li; Zhibin Guo; Jinghao Liu; Sen Wei; Dian Ren; Gang Chen; Song Xu; Jun Chen Journal: Thorac Cancer Date: 2017-11-28 Impact factor: 3.500